Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA).
Saved in:
| Title: | Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). |
|---|---|
| Authors: | Vaz, Sofia C.1,2 (AUTHOR) sofia.vaz@fundacaochampalimaud.pt, Woll, John Patrick Pilkington3 (AUTHOR), Cardoso, Fatima4 (AUTHOR), Groheux, David5,6,7 (AUTHOR), Cook, Gary J. R.8,9,10 (AUTHOR), Ulaner, Gary A.11,12 (AUTHOR), Jacene, Heather13,14 (AUTHOR), Rubio, Isabel T.15 (AUTHOR), Schoones, Jan W.16 (AUTHOR), Peeters, Marie-Jeanne Vrancken17,18 (AUTHOR), Poortmans, Philip19,20 (AUTHOR), Mann, Ritse M.21 (AUTHOR), Graff, Stephanie L.22,23 (AUTHOR), Dibble, Elizabeth H.24 (AUTHOR) edibble@lifespan.org, de Geus-Oei, Lioe-Fee2,25,26 (AUTHOR) l.f.de_geus-oei@lumc.nl |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 9, p2706-2732. 27p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
